Pellosi, Diogo Silva; Paula, Leonardo Barcelos de 
; Melo, Maryanne Trafani de ; Tedesco, Antônio Cláudio
Fonte: Molecular Pharmaceutics. Unidade: FFCLRP
Assuntos: NANOTECNOLOGIA, GLIOMA, NANOPARTÍCULAS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PELLOSI, Diogo Silva et al. Targeted and synergic glioblastoma treatment: multifunctional nanoparticles delivering verteporfin as adjuvant therapy for temozolomide chemotherapy. Molecular Pharmaceutics, v. 16, n. 3, p. 1009-1024, 2019Tradução . . Disponível em: https://doi.org/10.1021/acs.molpharmaceut.8b01001. Acesso em: 01 set. 2024.APA
Pellosi, D. S., Paula, L. B. de, Melo, M. T. de, & Tedesco, A. C. (2019). Targeted and synergic glioblastoma treatment: multifunctional nanoparticles delivering verteporfin as adjuvant therapy for temozolomide chemotherapy. Molecular Pharmaceutics, 16( 3), 1009-1024. doi:10.1021/acs.molpharmaceut.8b01001NLM
Pellosi DS, Paula LB de, Melo MT de, Tedesco AC. Targeted and synergic glioblastoma treatment: multifunctional nanoparticles delivering verteporfin as adjuvant therapy for temozolomide chemotherapy [Internet]. Molecular Pharmaceutics. 2019 ; 16( 3): 1009-1024.[citado 2024 set. 01 ] Available from: https://doi.org/10.1021/acs.molpharmaceut.8b01001Vancouver
Pellosi DS, Paula LB de, Melo MT de, Tedesco AC. Targeted and synergic glioblastoma treatment: multifunctional nanoparticles delivering verteporfin as adjuvant therapy for temozolomide chemotherapy [Internet]. Molecular Pharmaceutics. 2019 ; 16( 3): 1009-1024.[citado 2024 set. 01 ] Available from: https://doi.org/10.1021/acs.molpharmaceut.8b01001
